Afatinib-loaded inhalable PLGA nanoparticles for localized therapy of non-small cell lung cancer (NSCLC)—development and in-vitro efficacy
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Afatinib-loaded inhalable PLGA nanoparticles for localized therapy of non-small cell lung cancer (NSCLC)—development and in-vitro efficacy
Authors
Keywords
-
Journal
Drug Delivery and Translational Research
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-06-17
DOI
10.1007/s13346-020-00802-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Development of inhalable quinacrine loaded bovine serum albumin modified cationic nanoparticles: Repurposing quinacrine for lung cancer therapeutics
- (2020) Bhuvaneshwar Vaidya et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- The solid progress of nanomedicine
- (2020) João Pedro Martins et al. Drug Delivery and Translational Research
- Systematic Development and Optimization of Inhalable Pirfenidone Liposomes for Non-Small Cell Lung Cancer Treatment
- (2020) Vineela Parvathaneni et al. Pharmaceutics
- The Position of Inhaled Chemotherapy in the Care of Patients with Lung Tumors: Clinical Feasibility and Indications According to Recent Pharmaceutical Progresses
- (2019) Rémi Rosière et al. Cancers
- Strategies to overcome acquired resistance to EGFR TKI in the treatment of non-small cell lung cancer
- (2019) J. Gao et al. Clinical & Translational Oncology
- Preparation and Characterization of Itraconazole- or Miconazole-Loaded PLGA Microspheres
- (2019) Kazuhiro Matsuura et al. CHEMICAL & PHARMACEUTICAL BULLETIN
- Penetration and Uptake of Nanoparticles in 3D Tumor Spheroids
- (2019) Aleksandra Tchoryk et al. BIOCONJUGATE CHEMISTRY
- Tyrosine kinase inhibitor conjugated quantum dots for non-small cell lung cancer (NSCLC) treatment
- (2019) Nishant S. Kulkarni et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Design of Poly(lactic-co-glycolic Acid) (PLGA) Nanoparticles for Vaginal Co-Delivery of Griffithsin and Dapivirine and Their Synergistic Effect for HIV Prophylaxis
- (2019) Haitao Yang et al. Pharmaceutics
- Poly(lactic-co-glycolic acid) Nanoparticles Loaded with Callistemon citrinus Phenolics Exhibited Anticancer Properties against Three Breast Cancer Cell Lines
- (2019) Rashid Ahmed et al. JOURNAL OF FOOD QUALITY
- Preparation, Optimization, and In Vivo Evaluation of Nanoparticle-Based Formulation for Pulmonary Delivery of Anticancer Drug
- (2019) Chishti et al. Medicina-Lithuania
- On the issue of transparency and reproducibility in nanomedicine
- (2019) Hon S. Leong et al. Nature Nanotechnology
- Inhalable nanotherapeutics to improve treatment efficacy for common lung diseases
- (2019) Caleb F. Anderson et al. Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology
- Development and Evaluation of Paclitaxel-Loaded Aerosol Nanocomposite Microparticles and Their Efficacy Against Air-Grown Lung Cancer Tumor Spheroids
- (2019) Elisa A. Torrico Guzmán et al. ACS Biomaterials-Science & Engineering
- Metformin-Encapsulated Liposome Delivery System: An Effective Treatment Approach against Breast Cancer
- (2019) Snehal K. Shukla et al. Pharmaceutics
- Nanomedicine Approaches for the Pulmonary Treatment of Cystic Fibrosis
- (2019) Cecilia Velino et al. Frontiers in Bioengineering and Biotechnology
- Inhaled Therapy in Respiratory Disease: The Complex Interplay of Pulmonary Kinetic Processes
- (2018) Jens Markus Borghardt et al. Canadian Respiratory Journal
- Critical Parameters for Particle-Based Pulmonary Delivery of Chemotherapeutics
- (2018) Ali Dabbagh et al. Journal of Aerosol Medicine and Pulmonary Drug Delivery
- Inhalable particulate drug delivery systems for lung cancer therapy: Nanoparticles, microparticles, nanocomposites and nanoaggregates
- (2018) Hadeer M. Abdelaziz et al. JOURNAL OF CONTROLLED RELEASE
- Afatinib restrains K-RAS–driven lung tumorigenesis
- (2018) Herwig P. Moll et al. Science Translational Medicine
- Strategies to improve tumor penetration of nanomedicines through nanoparticle design
- (2018) Ya-Ru Zhang et al. Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology
- Nanopharmaceuticals and nanomedicines currently on the market: challenges and opportunities
- (2018) Fatemeh Farjadian et al. Nanomedicine
- Insight into Cellular Uptake and Intracellular Trafficking of Nanoparticles
- (2018) Parisa Foroozandeh et al. Nanoscale Research Letters
- Cyclodextrin modified erlotinib loaded PLGA nanoparticles for improved therapeutic efficacy against non-small cell lung cancer
- (2018) Bhuvaneshwar Vaidya et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Effective use of nanocarriers as drug delivery systems for the treatment of selected tumors
- (2017) Fakhar ud Din et al. International Journal of Nanomedicine
- Spermidine-mediated poly(lactic-co-glycolic acid) nanoparticles containing fluorofenidone for the treatment of idiopathic pulmonary fibrosis
- (2017) Jing Tang et al. International Journal of Nanomedicine
- Development of Optimized, Inhalable, Gemcitabine-Loaded Gelatin Nanocarriers for Lung Cancer
- (2017) Susanne R. Youngren-Ortiz et al. Journal of Aerosol Medicine and Pulmonary Drug Delivery
- Bone-targeted cabazitaxel nanoparticles for metastatic prostate cancer skeletal lesions and pain
- (2017) Andrew S Gdowski et al. Nanomedicine
- Multicellular tumor spheroids: a relevant 3D model for the in vitro preclinical investigation of polymer nanomedicines
- (2017) Gianpiero Lazzari et al. Polymer Chemistry
- Identification of a New Potent Inhibitor Targeting KRAS in Non-small Cell Lung Cancer Cells
- (2017) Chun Xie et al. Frontiers in Pharmacology
- Impact of multicellular tumor spheroids as an in vivo-like tumor model on anticancer drug response
- (2016) BIANCA GALATEANU et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Enzyme-responsive multistage vector for drug delivery to tumor tissue
- (2016) Yu Mi et al. PHARMACOLOGICAL RESEARCH
- Irreversible Multitargeted ErbB Family Inhibitors for Therapy of Lung and Breast Cancer
- (2015) Deepa Subramaniam et al. CURRENT CANCER DRUG TARGETS
- Pulmonary drug delivery: a review on nanocarriers for antibacterial chemotherapy
- (2015) M. Moreno-Sastre et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Inhalable self-assembled albumin nanoparticles for treating drug-resistant lung cancer
- (2015) Seong Ho Choi et al. JOURNAL OF CONTROLLED RELEASE
- Nanotechnology approaches for inhalation treatment of lung diseases
- (2015) Andriy Kuzmov et al. JOURNAL OF CONTROLLED RELEASE
- Afatinib increases sensitivity to radiation in non-small cell lung cancer cells with acquired EGFR T790M mutation
- (2015) Shirong Zhang et al. Oncotarget
- Afatinib versus cisplatin plus gemcitabine for first-line treatment of Asian patients with advanced non-small-cell lung cancer harbouring EGFR mutations (LUX-Lung 6): an open-label, randomised phase 3 trial
- (2014) Yi-Long Wu et al. LANCET ONCOLOGY
- Transferrin-conjugated doxorubicin-loaded lipid-coated nanoparticles for the targeting and therapy of lung cancer
- (2014) YAJUN GUO et al. Oncology Letters
- The effect of particle agglomeration on the formation of a surface-connected compartment induced by hydroxyapatite nanoparticles in human monocyte-derived macrophages
- (2013) Karin H. Müller et al. BIOMATERIALS
- Liposomal fasudil, a rho-kinase inhibitor, for prolonged pulmonary preferential vasodilation in pulmonary arterial hypertension
- (2013) Vivek Gupta et al. JOURNAL OF CONTROLLED RELEASE
- Spheroid culture as a tool for creating 3D complex tissues
- (2013) Eelco Fennema et al. TRENDS IN BIOTECHNOLOGY
- Epidemiology of Lung Cancer
- (2013) Carole Ridge et al. SEMINARS IN INTERVENTIONAL RADIOLOGY
- Three-dimensional cell culture: the missing link in drug discovery
- (2012) Susan Breslin et al. DRUG DISCOVERY TODAY
- Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial
- (2012) Rafael Rosell et al. LANCET ONCOLOGY
- Afatinib pharmacokinetics and metabolism after oral administration to healthy male volunteers
- (2011) Peter Stopfer et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Characterization and anti-tumor activity of chemical conjugation of doxorubicin in polymeric micelles (DOX-P) in vitro
- (2011) Ying-Zheng Zhao et al. CANCER LETTERS
- Influence of particle size on regional lung deposition – What evidence is there?
- (2011) Thiago C. Carvalho et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study
- (2011) Caicun Zhou et al. LANCET ONCOLOGY
- Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier
- (2011) Hirenkumar K. Makadia et al. Polymers
- Matrix Metalloproteinase-9 Is Increased in Obese Subjects and Decreases in Response to Pioglitazone
- (2010) Resat Unal et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Gefitinib or Chemotherapy for Non–Small-Cell Lung Cancer with Mutated EGFR
- (2010) Makoto Maemondo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Formulation Optimization of Etoposide Loaded PLGA Nanoparticles by Double Factorial Design and their Evaluation
- (2010) Khushwant Yadav et al. Current Drug Delivery
- The uptake and intracellular fate of PLGA nanoparticles in epithelial cells
- (2009) Malgorzata S. Cartiera et al. BIOMATERIALS
- Improved cellular uptake of chitosan-modified PLGA nanospheres by A549 cells
- (2009) Kohei Tahara et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial
- (2009) Tetsuya Mitsudomi et al. LANCET ONCOLOGY
- Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
- (2009) Tony S. Mok et al. NEW ENGLAND JOURNAL OF MEDICINE
- Preparation and characterization of PLGA particles for subcutaneous controlled drug release by membrane emulsification
- (2007) G. Gasparini et al. COLLOIDS AND SURFACES B-BIOINTERFACES
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now